Aditxt, Inc. Class of Warrant or Right, Outstanding
Aditxt, Inc. (ADTX) had Class of Warrant or Right, Outstanding of 6.25 thousand shares as of 2026-02-03, per its 10-Q filed 2026-05-20.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-05-20
- 2026-02-03: Class of Warrant or Right, Outstanding 6.25K shares.
- 2023-09-01: Class of Warrant or Right, Outstanding 9.09K shares.
- 2023-08-31: Class of Warrant or Right, Outstanding 60.00K shares.
- 2022-08-11: Class of Warrant or Right, Outstanding 47.18K shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2026-02-03 | 6.25K shares 10-Q · filed 2026-05-20 |
| 2023-09-01 | 9.09K shares 10-K · filed 2024-04-16 |
| 2023-08-31 | 60.00K shares 10-K · filed 2024-04-16 |
| 2022-08-11 | 47.18K shares 10-K · filed 2023-04-17 |
| 2021-09-30 | 205.28K shares 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |